Fagron NV
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
07 feb 2014 - 07:30
Statutaire naam
Fagron NV
Titel
ARSEUS ACHIEVES TURNOVER GROWTH OF 18.6% AND REALISES ORGANIC GROWTH OF 12.6%
Bericht
EBITDA INCREASES 30.5%
ARSEUS WILL DIVEST REMAINING DENTAL AND MEDICAL ACTIVITIES IN 2014
Key points in 2013, based on continuing operations[2]:
Turnover increased 14.4% to € 386.1 million
Organic turnover growth was 8.6% (12.6% at constant exchange rates)
EBITDA increased 30.5% to € 88.0 million
EBIT increased 37.4% to € 73.9 million
Net financial debt/annualised REBITDA ratio was 2.61 at 31 December 2013
Divestment of all remaining dental and medical activities in 2014
Dividend proposal for 2013: € 0.72 per share, 20.0% higher than in 2012
Outlook 2014[3]: Turnover of at least € 480 million with an REBITDA[4] margin of 26%
Datum laatste update: 24 februari 2026